ACRS vs MSFT · rev $3.6M vs P/E 39, rev $331.84B
Aclaris Therapeutics Inc (ACRS) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
ACRS currently screens at market cap $615.9M. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the ACRS and MSFT stock pages for the full models.
Not investment advice.